ArticleJournal of the American Heart Association2025
Outcomes of End Stage Renal Disease in Patients With Infective Endocarditis: A Nationwide Population-Based Study.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Impact of valve position and prosthesis type on outcomes of valve replacement in end-stage renal disease patients with infective endocarditis.JTCVS open · 2026Article
- Changing Patterns in Infective Endocarditis: A Contemporary Epidemiological Perspective.Pathogens (Basel, Switzerland) · 2026Review
- Article
- Article
- Comparative effectiveness of adjunctive rifampicin versus gentamicin for prosthetic valve endocarditis due toJAC-antimicrobial resistance · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfective endocarditis (IE) is a serious and potentially lethal condition in patients with end-stage renal disease (ESRD). This study aimed to describe the clinical features, provide epidemiology information, and compare short and long-term outcomes of IE in patients with ESRD.
methodsPatients who were admitted due to IE from 2001 to 2021 were identified from Taiwan's National Health Insurance Research Database and grouped based on whether they were undergoing chronic dialysis with ESRD. Primary outcomes were surgical rate during the index IE hospitalization, in-hospital death, and all-cause death after surviving to discharge.
resultsA total of 27 336 patients were included, with 3258 (11.9%) receiving dialysis. The surgical rate significantly increased over years in both the groups with and without ESRD. In-hospital and late mortalities were significantly higher in patients with ESRD (32.9% versus 16.9%, and 76.0% versus 48.1%, respectively). The predominant pathogen was methicillin-resistant
conclusionsPatients with ESRD have higher in-hospital and late mortality rates, more complications, and a higher recurrence rate of IE than patients without ESRD. The long-term survival rates were higher in both the groups with and without ESRD and non-ESRD who underwent surgeries for IE; therefore, surgery may be considered if the patient's condition permits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.